Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Receptor tyrosine kinase c-ros oncogene 1 (ROS1) is a type I integral membrane protein with intrinsic tyrosine kinase activity. It functions as a growth or differentiation factor receptor, playing a role in epithelial cell differentiation. In cancer, chromosomal rearrangements can create fusion genes involving ROS1, leading to constitutive activation of its kinase function and driving oncogenesis. It is a therapeutic target in cancers such as non-small cell lung cancer (NSCLC), with several small-molecule inhibitors developed to target its aberrant activity.
Small-molecule inhibitors that target aberrant ROS1 kinase activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Receptor tyrosine kinase c-ros oncogene 1 (ROS1).